Chao-Hung Hung

29PUBLICATIONS
72CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMetabolic medicineNutrigenomics and personalised nutritionCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jul 13, 2026
Survival outcomes of conversion curative therapy following atezolizumab-bevacizumab in advanced hepatocellular carcinoma.

|Jun 28, 2026
Risk Group Stratification for True Early Recurrence After Ablation for Hepatomas.

|May 13, 2026
Prognostic Significance of Histologic Steatotic Liver Disease in Curatively Resected Non-B, Non-C Hepatocellular Carcinoma.

|May 08, 2026
Predictive Value of Nutrition Indices in Advanced Hepatocellular Carcinoma Patients Treated With Lenvatinib.

|Apr 08, 2026
Predictors of True Early Recurrence in Patients Undergoing Radiofrequency Ablation for Hepatocellular Carcinoma.

Yi-Hao Yen, Kwong-Ming Kee, Chao-Hung Hung

|Mar 18, 2026
Editorial: Regorafenib Plus Nivolumab in Advanced Hepatocellular Carcinoma-A Step Toward Mechanism-Guided Second-Line Therapy.

Yuan-Hung Kuo, Chao-Hung Hung

Pageof 5

Frequent Collaborators

10 joint publications

Chien-Hung Chen

8 joint publications

Sheng-Nan Lu

7 joint publications

Jing-Houng Wang

6 joint publications

Ming-Lung Yu